Dishman Pharmaceuticals and Chemicals has received Establishment Inspection Report (EIR) from the USFDA for its Bavla facility on February 01, 2017. Thus, the company’s facilities in Bavla, Naroda and Switzerland continue to be approved by the USFDA. The US Food and Drug Administration (USFDA) had inspected Bavla facility in July, 2016.
Dishman Pharmaceuticals and Chemicals is a global outsourcing partner for the pharmaceutical industry, offering a portfolio of development, scale-up and manufacturing services. It improves its customers’ businesses by providing a range of development and manufacturing solutions at locations in Europe and in India.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1669.00 |
| Dr. Reddys Lab | 1236.05 |
| Cipla | 1232.00 |
| Zydus Lifesciences | 936.50 |
| Lupin | 2327.10 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: